1.5(top 50%)
impact factor
523(top 50%)
papers
9.5K(top 20%)
citations
48(top 20%)
h-index
1.5(top 50%)
impact factor
574
all documents
10.0K
doc citations
74(top 20%)
g-index

Top Articles

#TitleJournalYearCitations
1The Discovery and Development of Selective Estrogen Receptor Modulators (SERMs) for Clinical PracticeCurrent Clinical Pharmacology2013297
2Trends in Utilization of the Pharmacological Potential of ChalconesCurrent Clinical Pharmacology2010269
3Pharmacometrics of Stilbenes: Seguing Towards the ClinicCurrent Clinical Pharmacology2006258
4Monoclonal Antibodies: A ReviewCurrent Clinical Pharmacology2018232
5The Molecular Basis of Class Side Effects Due to Treatment with Inhibitors of the VEGF/VEGFR PathwayCurrent Clinical Pharmacology2008175
6Applications of Artificial Neural Networks in Medical ScienceCurrent Clinical Pharmacology2007164
7Pharmacokinetics and Pharmacokinetic Variability of Heroin and its Metabolites: Review of the LiteratureCurrent Clinical Pharmacology2006160
8Evidence-Based Efficacy of Adaptogens in Fatigue, and Molecular Mechanisms Related to their Stress-Protective ActivityCurrent Clinical Pharmacology2009136
9The Pharmacogenetics of CYP2C9 and CYP2C19: Ethnic Variation and Clinical SignificanceCurrent Clinical Pharmacology2007115
10Ethanol Metabolism and Effects: Nitric Oxide and its InteractionCurrent Clinical Pharmacology2007104
11The Pharmacokinetics and Pharmacodynamics of Levodopa in the Treatment of Parkinsons DiseaseCurrent Clinical Pharmacology2007103
12Endocannabinoid System: A Multi-Facet Therapeutic TargetCurrent Clinical Pharmacology2016102
13Tirapazamine: From Bench to Clinical TrialsCurrent Clinical Pharmacology2006100
14Abrogation of the G2 Checkpoint by Inhibition of Wee-1 Kinase Results in Sensitization of p53-Deficient Tumor Cells to DNA-Damaging AgentsCurrent Clinical Pharmacology201095
15Current State of the Art of New Tubulin Inhibitors in the ClinicCurrent Clinical Pharmacology200694
16Barriers to Optimising Prescribing and Deprescribing in Older Adults with Dementia: A Narrative ReviewCurrent Clinical Pharmacology201589
17Designer Drugs on the Internet: A Phenomenon Out-of-Control? The Emergence of Hallucinogenic Drug Bromo-DragonflyCurrent Clinical Pharmacology201187
18Pediatric Off-Label and Unlicensed Drug Use and Its ImplicationsCurrent Clinical Pharmacology201784
19Health Consequences of Catabolic Synthesis of Hippuric Acid in HumansCurrent Clinical Pharmacology201082
20Alcohol Consumption, Dementia and Cognitive Decline: An Overview of Systematic ReviewsCurrent Clinical Pharmacology201581
21Ability of older people with dementia or cognitive impairment to manage medicine regimens: a narrative reviewCurrent Clinical Pharmacology201579
22Recent Advances in Obesity PharmacotherapyCurrent Clinical Pharmacology200975
23Clinical Pharmacogenomics of Thiopurine S-methyltransferaseCurrent Clinical Pharmacology200671
24The Pharmacological Management of Intrahepatic Cholestasis of PregnancyCurrent Clinical Pharmacology201170
25Melatonin in Autism Spectrum DisordersCurrent Clinical Pharmacology201470
26How to Design and Validate A Questionnaire: A GuideCurrent Clinical Pharmacology201970
27Clinical Pharmacokinetics of Systemically Administered AntimycoticsCurrent Clinical Pharmacology200768
28Inappropriate Drug Use in People with Cognitive Impairment and Dementia: A Systematic ReviewCurrent Clinical Pharmacology201568
29Amyloid Beta Protein and Tau in Cerebrospinal Fluid and Plasma as Biomarkers for Dementia: A Review of Recent LiteratureCurrent Clinical Pharmacology200868
30Pharmacokinetics and Metabolic Drug InteractionsCurrent Clinical Pharmacology200667
31Overuse of PPIs in Patients at Admission, During Hospitalisation, and at Discharge in a Terciary Spanish HospitalCurrent Clinical Pharmacology201067
32Metformin as a Radiation Modifier; Implications to Normal Tissue Protection and Tumor SensitizationCurrent Clinical Pharmacology201965
33Prevalence of Analgesic Use and Pain in People with and without Dementia or Cognitive Impairment in Aged Care Facilities: A Systematic Review and Meta-AnalysisCurrent Clinical Pharmacology201564
34Improving Adherence to Antipsychotic PharmacotherapyCurrent Clinical Pharmacology200662
35Influence of Enzyme-Inducing Antiepileptic Drugs on Trough Level of Imatinib in Glioblastoma PatientsCurrent Clinical Pharmacology200862
36Role of Histone Deacetylases and Their Inhibitors in Cancer Biology and TreatmentCurrent Clinical Pharmacology201062
37Clonidine: Clinical Pharmacology and Therapeutic Use in Pain ManagementCurrent Clinical Pharmacology201161
38Anti-Cancer Properties of Nigella spp. Essential Oils and their Major Constituents, Thymoquinone and β-ElemeneCurrent Clinical Pharmacology200957
39Polyethylenimine as a Promising Vector for Targeted siRNA DeliveryCurrent Clinical Pharmacology201257
40Pharmacogenetics of Irinotecan Disposition and Toxicity: A ReviewCurrent Clinical Pharmacology201056
41Nanotechnology for Delivery of Drugs and Biomedical ApplicationsCurrent Clinical Pharmacology201055
42The Pharmacokinetics of Long-Acting Antipsychotic MedicationsCurrent Clinical Pharmacology201454
43Metabolic Correction in the Management of Diabetic Peripheral Neuropathy: Improving Clinical Results Beyond Symptom ControlCurrent Clinical Pharmacology201153
44Curcuminoids Plus Piperine Modulate Adipokines in Type 2 Diabetes MellitusCurrent Clinical Pharmacology201853
45Therapeutic Rationale for mTOR Inhibition in Advanced Renal Cell CarcinomaCurrent Clinical Pharmacology201152
46Towards a Clarification of Terminology in Medicine Taking Behavior: Compliance, Adherence and Concordance are Related Although Different Terms with Different UsesCurrent Clinical Pharmacology201151
47GLP-1 Agonists Exenatide and Liraglutide: A Review About Their Safety and EfficacyCurrent Clinical Pharmacology201251
48Cyclosporin and Organ Specific Toxicity: Clinical Aspects, Pharmacogenetics and PerspectivesCurrent Clinical Pharmacology200850
49Comprehensive Approach to Sarcopenia TreatmentCurrent Clinical Pharmacology201450
50Clinical Efficacy and Effectiveness of Ursodeoxycholic Acid in Cholestatic Liver DiseasesCurrent Clinical Pharmacology200749